This company has been marked as potentially delisted and may not be actively trading. Flexion Therapeutics (FLXN) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsSustainabilityTrendsBuy This Stock FLXN vs. MENS, GMTX, MOR, ZYME, CALT, ETHZ, SBTX, AVTE, NLTX, and BIOAShould you be buying Flexion Therapeutics stock or one of its competitors? The main competitors of Flexion Therapeutics include Jyong Biotech (MENS), Gemini Therapeutics (GMTX), MorphoSys (MOR), Zymeworks (ZYME), Calliditas Therapeutics AB (publ) (CALT), Flag Ship Acquisition (ETHZ), Silverback Therapeutics (SBTX), Aerovate Therapeutics (AVTE), Neoleukin Therapeutics (NLTX), and BioAge Labs (BIOA). Flexion Therapeutics vs. Its Competitors Jyong Biotech Gemini Therapeutics MorphoSys Zymeworks Calliditas Therapeutics AB (publ) Flag Ship Acquisition Silverback Therapeutics Aerovate Therapeutics Neoleukin Therapeutics BioAge Labs Jyong Biotech (NASDAQ:MENS) and Flexion Therapeutics (NASDAQ:FLXN) are both pharmaceutical preparations industry companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, media sentiment, valuation, profitability, risk, analyst recommendations, dividends and institutional ownership. Which has better valuation and earnings, MENS or FLXN? Jyong Biotech has higher earnings, but lower revenue than Flexion Therapeutics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioJyong BiotechN/AN/AN/AN/AN/AFlexion Therapeutics$85.55M15.03-$113.71M-$2.01-12.72 Do insiders & institutionals believe in MENS or FLXN? 90.0% of Flexion Therapeutics shares are held by institutional investors. 9.1% of Flexion Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Does the media prefer MENS or FLXN? In the previous week, Jyong Biotech had 4 more articles in the media than Flexion Therapeutics. MarketBeat recorded 4 mentions for Jyong Biotech and 0 mentions for Flexion Therapeutics. Jyong Biotech's average media sentiment score of 0.91 beat Flexion Therapeutics' score of 0.00 indicating that Jyong Biotech is being referred to more favorably in the media. Company Overall Sentiment Jyong Biotech Positive Flexion Therapeutics Neutral Do analysts prefer MENS or FLXN? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Jyong Biotech 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00Flexion Therapeutics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Is MENS or FLXN more profitable? Jyong Biotech has a net margin of 0.00% compared to Flexion Therapeutics' net margin of -100.32%. Company Net Margins Return on Equity Return on Assets Jyong BiotechN/A N/A N/A Flexion Therapeutics -100.32%N/A -44.26% SummaryJyong Biotech beats Flexion Therapeutics on 5 of the 8 factors compared between the two stocks. Get Flexion Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for FLXN and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding FLXN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart FLXN vs. The Competition Export to ExcelMetricFlexion TherapeuticsPharmaceutical Preparations IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.29B$1.03B$6.06B$10.57BDividend YieldN/A4.84%5.73%4.80%P/E Ratio-12.721.3285.0727.47Price / Sales15.03179.09518.67200.70Price / CashN/A17.6437.5761.53Price / Book-75.187.8412.336.87Net Income-$113.71M-$7.47M$3.32B$276.69M Flexion Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)FLXNFlexion TherapeuticsN/A$25.56+0.2%N/AN/A$1.29B$85.55M-12.72257MENSJyong BiotechN/A$53.54-2.8%N/AN/A$4.07BN/A0.0031GMTXGemini TherapeuticsN/A$67.89-2.0%N/A+50.7%$2.94BN/A-67.8930MORMorphoSysN/A$18.96flatN/AN/A$2.86B$238.28M-5.45730ZYMEZymeworks0.0668 of 5 stars$16.71+1.3%N/AN/A$1.26B$76.30M-17.23460News CoverageAnalyst UpgradeCALTCalliditas Therapeutics AB (publ)N/A$40.00flatN/AN/A$1.19B$1.60B-21.62180ETHZFlag Ship AcquisitionN/A$2.39+2.6%N/AN/A$392.99MN/A-0.167Gap DownSBTXSilverback TherapeuticsN/A$10.33+0.6%N/A-24.7%$372.48MN/A-4.2783High Trading VolumeAVTEAerovate TherapeuticsN/A$9.14+3.2%N/A-87.9%$264.92MN/A-3.0620News CoverageGap DownHigh Trading VolumeNLTXNeoleukin TherapeuticsN/A$23.47+1.6%N/A-36.0%$220.57MN/A-7.5590High Trading VolumeBIOABioAge Labs0.1874 of 5 stars$5.67+1.3%N/AN/A$203.45MN/A0.00N/A Related Companies and Tools Related Companies MENS Alternatives GMTX Alternatives MOR Alternatives ZYME Alternatives CALT Alternatives ETHZ Alternatives SBTX Alternatives AVTE Alternatives NLTX Alternatives BIOA Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:FLXN) was last updated on 10/15/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredGold surges past $3,600 … but this has beat gold by 1,000xGold has surged past $3,600 an ounce — up 45% in the past year — but one veteran metals analyst says the real ...Weiss Ratings | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Flexion Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Flexion Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
